SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-423193
Filing Date
2013-11-01
Accepted
2013-11-01 17:07:21
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d594046d10q.htm 10-Q 335615
2 EX-3.5 d594046dex35.htm EX-3.5 5448
3 EX-31.1 d594046dex311.htm EX-31.1 6772
4 EX-31.2 d594046dex312.htm EX-31.2 6788
5 EX-32.1 d594046dex321.htm EX-32.1 3251
6 EX-32.2 d594046dex322.htm EX-32.2 3228
  Complete submission text file 0001193125-13-423193.txt   3425221

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cndo-20130930.xml EX-101.INS 383479
8 XBRL TAXONOMY EXTENSION SCHEMA cndo-20130930.xsd EX-101.SCH 44955
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cndo-20130930_cal.xml EX-101.CAL 42120
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cndo-20130930_def.xml EX-101.DEF 156342
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cndo-20130930_lab.xml EX-101.LAB 343321
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cndo-20130930_pre.xml EX-101.PRE 229308
Mailing Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 781-652-4500
CORONADO BIOSCIENCES INC (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 131186717
SIC: 2834 Pharmaceutical Preparations